Quantum computing, neurostimulation, digital pathology, and lab-grown meat. Top deal news from MedTech and Biotech this week, summarised by Matt Lowdon below for you :). Congratulations to all involved.
➡️ Quantinuum, a quantum tech firm that has collaborated with—and received investment from—Amgen is now planning to go public.
➡️ Neurostimulation device company Mobia Medical priced its initial public offering at the midpoint of the range ahead of its trading debut on Friday, raising roughly $150M in gross proceeds.
➡️ Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
➡️ Banyan BioInnovations is debuting with more than $100m aimed at developing independent companies for promising clinical-stage treatments, plus a partnership with global CRO ICON plc.
➡️ Blackstone invests $250M in Anagram Therapeutics, Inc. to reduce burden of cystic fibrosis complication
➡️ Roche is set to pay out $750 million upfront to acquire digital pathology specialist PathAI in a move by the pharma giant to accelerate the use of artificial intelligence in diagnostic algorithms.
➡️ GSK pens $1B deal with China’s SiranBio for oligonucleotide that could reduce abdominal fat
➡️ Signadori Bio a preclinical-stage biopharma company developing a next generation, off-the-shelf, in vivo engineered, monocyte immunotherapy platform to treat solid tumours has raised €11.1m.
➡️ Bayer has struck a deal to buy Perfuse Therapeutics for $300 million upfront. The buyout, which includes up to $2.15 billion in milestones, will give Bayer control of an eye disease implant
➡️ Scarlet Therapeutics Ltd has raised £3.2 m to take therapies based on red blood cells to in vivo proof of concept, building on evidence that natural and lab-grown cells have comparable half-lives.
➡️ Basel-based Windward Bio did it again and has raised another three-digit millions – $165 million to be exact – to advance a pipeline of long-acting immunology therapies
➡️ Meatly, a London-based firm that became the first company in Europe approved to sell lab-grown meat in 2024, is now planning to open the continent’s “largest cultivated meat facility” after securing new funding.